Strachan D, Sibbald B, Weiland S: Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997, 8: 161-76. 10.1111/j.1399-3038.1997.tb00156.x.
Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001, 108: S147-334. 10.1067/mai.2001.118891.
Yawn BP, Yunginger JW, Wollan PC: Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol. 1999, 103: 54-9. 10.1016/S0091-6749(99)70525-7.
Togias AG: Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol. 2000, 106: S247-50. 10.1067/mai.2000.110157.
Vinuya RZ: Upper airway disorders and asthma: a syndrome of airway inflammation. Ann Allergy Asthma Immunol. 2002, 88: 8-15. 10.1016/S1081-1206(10)62023-6.
Leynaert B, Neukirch F, Demoly P, Bousquet J: Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 2000, 106: S201-5. 10.1067/mai.2000.110151.
Chen Y, Johansen H: Population aged 12 and over who report that they have been diagnosed by a health professional as having asthma [tables 104-0001 and 105-0001]. Statistics Canada, CANSIM; report number 2004002. 2004, 16 (2):
Settipane RJ, Hagy GW, Settipane GA: Longterm risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. 1994, 15: 21-5. 10.2500/108854194778816634.
Guerra S, Sherrill DL, Martinez FD, Barbee RA: Rhinitis as an independent risk factor for adultonset asthma. J Allergy Clin Immunol. 2002, 109: 419-25. 10.1067/mai.2002.121701.
Leynaert B, Bousquet J, Neukirch C: Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999, 104: 301-4. 10.1016/S0091-6749(99)70370-2.
Durham SR: Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy. 1998, 28 (Suppl 2): 11-6.
Bradley BL, Azzawi M, Jacobson M: Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol. 1991, 88: 661-74. 10.1016/0091-6749(91)90160-P.
Varga EM, Jacobson MR, Till SJ: Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy. 1999, 54: 338-45. 10.1034/j.1398-9995.1999.00957.x.
KleinJan A, Dijkstra MD, Boks SS: Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol. 1999, 103: 441-50. 10.1016/S0091-6749(99)70469-0.
Nag S, Lamkhioued B, Renzi PM: Interleukin-2-induced increased airway responsiveness and lung Th2 cytokine expression occur after antigen challenge through the leukotriene pathway. Am J Respir Crit Care Med. 2002, 165: 1540-5. 10.1164/rccm.2109012.
Bousquet J, Jacquot W, Vignola AM: Allergic rhinitis: a disease remodeling the upper airways?. J Allergy Clin Immunol. 2004, 113: 43-9. 10.1016/j.jaci.2003.09.047.
Ramsdale EH, Morris MM, Roberts RS, Hargreave FE: Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol. 1985, 75: 573-7. 10.1016/0091-6749(85)90032-6.
Corren J, Adinoff AD, Buchmeier AD, Irvin CG: Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992, 90: 250-6. 10.1016/0091-6749(92)90079-H.
Corren J, Adinoff AD, Irvin CG: Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol. 1992, 89: 611-8. 10.1016/0091-6749(92)90329-Z.
Foresi A, Leone C, Pelucchi A: Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol. 1997, 100: 58-64. 10.1016/S0091-6749(97)70195-7.
Sale R, Silvestri M, Battistini E: Nasal inflammation and bronchial reactivity to methacholine in atopic children with respiratory symptoms. Allergy. 2003, 58: 1171-5. 10.1034/j.1398-9995.2003.00286.x.
Gaga M, Lambrou P, Papageorgiou N: Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy. 2000, 30: 663-9. 10.1046/j.1365-2222.2000.00804.x.
Riccio AM, Tosca MA, Cosentino C: Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy. 2002, 32: 422-6. 10.1046/j.1365-2222.2002.01315.x.
Yasruel Z, Humbert M, Kotsimbos TC: Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. Am J Respir Crit Care Med. 1997, 155: 1413-8.
Ulrik CS: Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy. 1995, 25: 820-7. 10.1111/j.1365-2222.1995.tb00024.x.
Humbert M: Airways inflammation in asthma and chronic bronchitis. Clin Exp Allergy. 1996, 26: 735-7. 10.1111/j.1365-2222.1996.tb00602.x.
Humbert M, Corrigan CJ, Kimmitt P: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 1997, 156: 704-8.
Braunstahl GJ, Overbeek SE, Kleinjan A: Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001, 107: 469-76. 10.1067/mai.2001.113046.
Chakir J, Laviolette M, Turcotte H: Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol. 2000, 106: 904-10. 10.1067/mai.2000.110100.
Chakir J, Laviolette M, Boutet M: Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest. 1996, 75: 735-44.
Braunstahl GJ, Kleinjan A, Overbeek SE: Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000, 161: 2051-7.
Braunstahl GJ, Overbeek SE, Fokkens WJ: Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med. 2001, 164: 858-65.
Inman MD: Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. J Allergy Clin Immunol. 2000, 106: S235-41. 10.1067/mai.2000.110155.
Denburg J: The bone marrow and airway inflammation: evidence for allergy as a systemic disease. Clin Exp Allergy Review. 2003, 3: 23-7. 10.1046/j.1472-9725.2003.00058.x.
Sehmi R, Wood LJ, Watson R: Allergeninduced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest. 1997, 100: 2466-75. 10.1172/JCI119789.
Wood LJ, Sehmi R, Dorman S: Allergeninduced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med. 2002, 166: 883-9. 10.1164/rccm.2108015.
Isogai S, Miyata S, Taha R: CD4 T cells migrate from airway to bone marrow after antigen inhalation in rats. J Allergy Clin Immunol. 2004, 113: 455-61. 10.1016/j.jaci.2003.11.035.
Robinson DS, North J, Zeibecoglou K: Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol. 1999, 118: 98-100. 10.1159/000024039.
Cameron L, Hamid Q, Wright E: Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol. 2000, 106: 46-52. 10.1067/mai.2000.107398.
Taramarcaz P, Gibson P: Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev. 2003, 4: CD003570-
Watson WT, Becker AB, Simons FE: Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol. 1993, 91: 97-101. 10.1016/0091-6749(93)90301-U.
Wilson AM, Orr LC, Sims EJ, Lipworth BJ: Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy. 2001, 31: 61-8.
Crystal-Peters J, Neslusan C, Crown WH, Torres A: Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002, 109: 57-62. 10.1067/mai.2002.120554.
Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST: Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002, 109: 636-42. 10.1067/mai.2002.123237.
Grant JA, Nicodemus CF, Findlay SR: Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995, 95: 923-32. 10.1016/S0091-6749(95)70090-0.
Aubier M, Neukirch C, Peiffer C, Melac M: Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy. 2001, 56: 35-42. 10.1034/j.1398-9995.2001.00629.x.
Wilson AM, Orr LC, Sims EJ: Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med. 2000, 162: 1297-301.
Greiff L, Andersson M, Svensson C: Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J. 1998, 11: 1268-73. 10.1183/09031936.98.11061268.
Ragab S, Parikh A, Darby YC, Scadding GK: An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy. 2001, 31: 1385-91. 10.1046/j.1365-2222.2001.01160.x.
Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ: A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy. 2001, 31: 616-24. 10.1046/j.1365-2222.2001.01088.x.
Walker SM, Pajno GB, Lima MT: Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001, 107: 87-93. 10.1067/mai.2001.112027.